Investigating the role of dysfunctional histone H3.3 in driving early neuronal development and pediatric high-grade gliomas
研究功能失调的组蛋白 H3.3 在驱动早期神经元发育和儿童高级别胶质瘤中的作用
基本信息
- 批准号:10296014
- 负责人:
- 金额:$ 42.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:ATRX geneAffectAgeAllelesAutomobile DrivingBrainBrain NeoplasmsCellsChildhoodChildhood Brain NeoplasmChildhood GliomaDepositionDevelopmentDiagnosisDiseaseEnsureEpigenetic ProcessExhibitsGene Expression ProfileGeneticGenetically Engineered MouseGenomic InstabilityGliomaGliomagenesisGoalsHistone H3HistonesHumanImpairmentKnock-inKnowledgeLeadMalignant NeoplasmsMediator of activation proteinMitochondriaModificationMolecularMolecular ChaperonesMutateMutationNeuronsOncogenicPatientsPediatric NeoplasmPoint MutationPrognosisReactive Oxygen SpeciesRoleSolid NeoplasmSwitch GenesTestingTherapeuticTranslationsUnited StatesUp-Regulationbaseeffective therapyepigenetic regulationepigenomehistone modificationin vivo Modelinsightloss of function mutationmutantneoplastic cellnerve stem cellneuroblastneuron developmentnew therapeutic targetnovelnovel therapeutic interventionpremalignantpreventtelomeretherapeutic developmenttherapeutic targettooltranscription factortumor
项目摘要
Summary Statement/Abstract
Pediatric brain tumors are the most common solid tumors in children, with approximately 5000 new cases
diagnosed per year in the United States. Around 17% of brain tumors in children age 0–14 years are high-grade
gliomas (HGGs), which are currently incurable. The lack of effective treatments highlights the urgent need to
identify mechanism-based therapeutic approaches. Substantial experimental evidence has recently revealed
that H3.3-G34R–harboring pediatric HGGs (pHGGs) exhibit high genomic instability and high-level expression
of neuronal markers, indicating that these tumors represent a distinct subtype of pHGG compared with other
types, including the one with an H3.3-K27M mutation. More than 90% of H3.3-G34R gliomas also harbor ATRX
loss-of-function mutations. Using a newly established genetically engineered murine model (GEMM), we
demonstrated that H3.3-G34R mutation and ATRX deletion in premalignant neural stem cells (PM-NSCs) with
the Trp53-/- background could strongly promote gliomagenesis. These tumors exhibit typical features of human
H3.3-G34R–harboring pHGGs, so this GEMM provides us with a faithful tool for studying the molecular
mechanisms underlying the synergistic effects of H3.3-G34R mutation and ATRX deletion and for identifying
novel therapeutic targets. We have found that H3.3-G34R mutation changes histone modifications both locally
and globally and leads to high expression of FoxD1 and HoxA1, transcription factors essential for early neuronal
development. Given that enrichments of FoxD1 and HoxA1 are associated with worse prognosis in glioma
patients, they provide 2 novel therapeutic targets for pHGGs. In addition, we found that ATRX loss leads to ALT
activation, which makes tumor cells sensitive to perturbation of their mitochondrial function. On the basis of these
observations, we hypothesize that distinctive epigenetic profiles induced by H3.3-G34R mutation and ATRX loss
drive gliomagenesis and lead to targetable vulnerabilities involving dysfunctional telomeres and impaired
mitochondrial activity. To test this hypothesis, we plan to 1) determine the roles of FoxD1 and HoxA1 in H3.3-
G34R–driven gliomagenesis, 2) define the therapeutic vulnerability induced by ATRX deficiency in pHGGs, and
3) elucidate the synergistic effect of H3.3-G34R mutation and ATRX loss on epigenetic reprogramming in
gliomas. The completion of the proposed studies will not only fill the gaps in our knowledge of how H3.3-G34R
and ATRX loss change the epigenome to lead to normal neuronal development and gliomagenesis, but also—
and more importantly—contribute to the development of therapeutic strategies that target pHGGs and provide
insights into the role of epigenetic regulation in brain development and gliomagenesis.
摘要/Abstract
小儿脑肿瘤是儿童中最常见的实体肿瘤,大约有5000例新发病例
每年在美国确诊的在0-14岁的儿童中,约17%的脑肿瘤是高级别的
神经胶质瘤(HGG),目前无法治愈。缺乏有效的治疗方法突出了迫切需要
确定基于机制的治疗方法。最近有大量的实验证据表明
携带H3.3-G34 R的儿科HGG(pHGG)表现出高基因组不稳定性和高水平表达,
的神经元标记物,表明这些肿瘤代表了一个独特的亚型pHGG相比,其他
类型,包括H3.3-K27 M突变的类型。超过90%的H3.3-G34 R胶质瘤也含有ATRX
功能丧失突变使用新建立的基因工程小鼠模型(GEMM),我们
证明了H3.3-G34 R突变和ATRX缺失在恶性前神经干细胞(PM-NSC)中,
Trp 53-/-背景可强烈促进胶质瘤的发生。这些肿瘤表现出人类的典型特征,
H3.3-G34 R的pHGG,因此该GEMM为我们提供了一个可靠的研究分子生物学的工具,
H3.3-G34 R突变和ATRX缺失的协同作用的潜在机制以及用于鉴定
新的治疗靶点。我们发现H3.3-G34 R突变改变了组蛋白修饰,
并导致FoxD 1和HoxA 1的高表达,FoxD 1和HoxA 1是早期神经元发育所必需的转录因子。
发展鉴于FoxD 1和HoxA 1的富集与胶质瘤的预后不良相关,
患者,他们为pHGG提供了2个新的治疗靶点。此外,我们发现ATRX损失导致ALT
激活,这使得肿瘤细胞对其线粒体功能的扰动敏感。根据这些
观察,我们假设H3.3-G34 R突变和ATRX丢失诱导的独特的表观遗传特征,
驱动胶质瘤的发生,并导致涉及功能失调的端粒和受损的靶向脆弱性,
线粒体活性为了验证这一假设,我们计划1)确定FoxD 1和HoxA 1在H3.3中的作用-
G34 R驱动的胶质瘤发生,2)定义由pHGG中ATRX缺陷诱导的治疗脆弱性,以及
3)阐明H3.3-G34 R突变和ATRX缺失对表观遗传重编程的协同作用,
神经胶质瘤完成拟议的研究不仅将填补我们对H3.3-G34 R如何
和ATRX损失改变表观基因组,导致正常的神经元发育和胶质瘤形成,但也-
更重要的是,有助于开发靶向pHGG的治疗策略,
深入了解表观遗传调控在大脑发育和胶质瘤形成中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jian Hu其他文献
Jian Hu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jian Hu', 18)}}的其他基金
The role of membrane homoeostasis of neural stem cell and glioma stem cells in neural development and gliomagenesis
神经干细胞和胶质瘤干细胞膜稳态在神经发育和胶质瘤发生中的作用
- 批准号:
10713009 - 财政年份:2023
- 资助金额:
$ 42.64万 - 项目类别:
Promoting remyelination in multiple sclerosis by simultaneously modulating myelin debris clearance and myelin lipid synthesis
通过同时调节髓磷脂碎片清除和髓磷脂脂质合成促进多发性硬化症的髓鞘再生
- 批准号:
10621894 - 财政年份:2022
- 资助金额:
$ 42.64万 - 项目类别:
Investigating the role of dysfunctional histone H3.3 in driving early neuronal development and pediatric high-grade gliomas
研究功能失调的组蛋白 H3.3 在驱动早期神经元发育和儿童高级别胶质瘤中的作用
- 批准号:
10416054 - 财政年份:2021
- 资助金额:
$ 42.64万 - 项目类别:
Transport, substrate specificity and regulation mechanisms of the ZIP transition metal transporters
ZIP过渡金属转运蛋白的转运、底物特异性和调控机制
- 批准号:
10383720 - 财政年份:2021
- 资助金额:
$ 42.64万 - 项目类别:
Transport, substrate specificity and regulation mechanisms of the ZIP transition metal transporters
ZIP过渡金属转运蛋白的转运、底物特异性和调控机制
- 批准号:
10616707 - 财政年份:2021
- 资助金额:
$ 42.64万 - 项目类别:
Structural and Mechanistic Characterization of the ZIP Metal Transporters
ZIP 金属运输机的结构和机械特性
- 批准号:
9923026 - 财政年份:2018
- 资助金额:
$ 42.64万 - 项目类别:
Role of Quaking gene in regulating the niche-independent stemness of glioma stem cells
Quak基因在调节胶质瘤干细胞的微环境独立干性中的作用
- 批准号:
10061559 - 财政年份:2017
- 资助金额:
$ 42.64万 - 项目类别:
Role of Quaking gene in regulating the niche-independent stemness of glioma stem cells
Quak基因在调节胶质瘤干细胞的微环境独立干性中的作用
- 批准号:
10310491 - 财政年份:2017
- 资助金额:
$ 42.64万 - 项目类别:
Role of Quaking gene in regulating the niche-independent stemness of glioma stem cells
Quak基因在调节胶质瘤干细胞的微环境独立干性中的作用
- 批准号:
10524200 - 财政年份:2017
- 资助金额:
$ 42.64万 - 项目类别:
Targeting glioma stem cells by perturbation of telomere maintenance mechanisms
通过扰动端粒维持机制靶向神经胶质瘤干细胞
- 批准号:
8928060 - 财政年份:2014
- 资助金额:
$ 42.64万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 42.64万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 42.64万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 42.64万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 42.64万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 42.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 42.64万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 42.64万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 42.64万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 42.64万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 42.64万 - 项目类别:
Miscellaneous Programs